Z-1069-2018 Class II Terminated
FDA device recall Z-1069-2018 was initiated by Diagnostica Stago, Inc. on Oct 25, 2017 and is designated Class II. Reason for recall: Confirmed defect of homogeneity where some reagent vials will give prolonged Prothrombin Time (decreased PT%). The recall status is terminated (terminated May 12, 2020).
Recall details
- Product Type
- Devices
- Report Date
- Mar 21, 2018
- Initiation Date
- Oct 25, 2017
- Termination Date
- May 12, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
STA - Neoplastine¿ Cl Plus ¿ (ref. 00606) Product Usage: Manual or automated determination of the prothrombin time (PT).
Reason for recall
Confirmed defect of homogeneity where some reagent vials will give prolonged Prothrombin Time (decreased PT%).
Distribution pattern
Nationally
Code information
Lot: 250041RX (Exp: 2018-02) Lot: 250077 (Exp: 2018-02) Lot: 250246RU (Exp: 2018-03) Lot: 251492 (Exp: 2018-09) Lot: 251308 (Exp: 2018-10) Lot: 251626 (Exp: 20 19-01) Lot: 251730 (Exp: 2019-02) Lot: 251772 (Exp: 2019-02)
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1069-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026